Aethlon Medical
AEMD
9 hedge funds and large institutions have $61K invested in Aethlon Medical in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 7 closing their positions.
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
31% less funds holding
Funds holding: 13 → 9 (-4)
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
67% less capital invested
Capital invested by funds: $185K → $61K (-$124K)
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$71.7K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$12K |
| 3 |
Wells Fargo
San Francisco,
California
|
+$7.17K |
| 4 |
Morgan Stanley
New York
|
+$2.39K |
AEMD Hedge Fund Activity: Q4 2019 in Review
9 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q4 2019, worth a combined $61K — down 67% from $185K a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of AEMD and 3 opened new positions — a net loss of 4 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $71.7K. The largest seller was Geode Capital Management, exiting entirely with an estimated $29K sold.
- 9 institutional investors held Aethlon Medical (AEMD) as of Q4 2019, down from 13 in Q3 2019.
- Funds reported $61K of Aethlon Medical stock for Q4 2019, down 67% quarter-over-quarter.
- 3 funds opened new Aethlon Medical positions in Q4 2019 and 7 closed out, a net change of -4 holders.
- The largest Aethlon Medical buyer in Q4 2019 was Renaissance Technologies, an estimated $71.7K added.
- The largest Aethlon Medical seller in Q4 2019 was Geode Capital Management, an estimated $29K sold.
Based on aggregated 13F filings for Q4 2019.